Virus Filtration Market to Witness Significant Growth by 2035
Virus filtration market is driven by the increasing demand for biologics and biosimilars, rising focus on biopharmaceutical safety, and stringent regulatory requirements for viral clearance in drug manufacturing processes. The growing adoption of advanced filtration technologies in vaccine production, blood & plasma processing, and recombinant protein manufacturing is further supporting market growth globally. In addition, increasing investments in biotechnology research and expanding pharmaceutical production capacities are accelerating the demand for efficient virus filtration systems across healthcare and life sciences industries.
Browse the full report description of “Virus Filtration Market Size, Share, Trends, Growth, Research and Analysis Report and Forecast, 2019-2025” at https://www.omrglobal.com/industry-reports/virus-filtration-market
Inge™ ultrafiltration modules segment is expected to account for a major market share in 2026
Inge™ ultrafiltration modules are expected to hold a major market share in 2026, primarily due to the increasing demand for high-performance membrane filtration systems in industrial water treatment, bioprocessing, and high-purity water applications. These systems are gaining significant adoption owing to their ability to improve filtration efficiency, reduce operational complexity, and minimize plant footprint in advanced purification facilities. The launch of new Inge™ ultrafiltration modules with integrated pre-filter technology by DuPont in April 2026 reflects the growing industry focus on compact and energy-efficient filtration solutions capable of supporting stringent purity requirements across pharmaceutical, biotechnology, and industrial processing sectors. The increasing need for sustainable and cost-efficient water treatment technologies is further contributing to the segment’s market expansion.
Virus removal filtration systems segment is expected to account for a major market share in 2026
Virus removal filtration systems are expected to hold a major market share in 2026, primarily driven by the growing global production of biologics, plasma-derived therapeutics, and advanced biopharmaceutical products requiring highly reliable viral safety measures. These filtration systems play a critical role in ensuring product purity, regulatory compliance, and contamination control during pharmaceutical manufacturing processes. The expansion of Planova™ virus removal filter production capacity by Asahi Kasei Life Science through a new spinning plant in Japan highlights the rising global demand for advanced virus filtration technologies in biologics manufacturing. Increasing investments in bioprocessing infrastructure and the rapid growth of the biopharmaceutical industry are further supporting the adoption of high-efficiency virus removal filtration systems worldwide.
Bioprocess purification and filtration segment is expected to account for a major market share in 2026
Bioprocess purification and filtration systems are expected to hold a major market share in 2026 due to the increasing demand for advanced downstream processing technologies in pharmaceutical and biotechnology manufacturing. These systems are extensively used for product purification, contaminant removal, and process optimization in biologics, vaccines, and cell therapy production facilities. The acquisition of Solventum’s Purification & Filtration business by Thermo Fisher Scientific in September 2025 reflects the growing strategic focus on expanding advanced filtration and bioprocessing capabilities to support large-scale pharmaceutical manufacturing operations. Rising investments in biologics production, increasing regulatory standards for product quality, and growing demand for efficient purification technologies are expected to significantly contribute to the growth of the bioprocess purification and filtration segment.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404